Metastasis organotropism in colorectal cancer: advancing toward innovative therapies

Kai He1,2, Zhihan Wang2, Maochao Luo2

  • 1School of Basic Medical Sciences and State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

PubMed

Insights

Distant metastasis in colorectal cancer (CRC) is driven by organotropism, where cancer cells target specific organs. Understanding these molecular mechanisms is key to developing new therapies for CRC metastasis.

Area of Science:

  • Oncology
  • Cancer Metastasis Research

Background:

  • Distant metastasis is a primary cause of mortality in colorectal cancer (CRC).
  • Organotropism, the targeting of specific organs by metastasis, is a key feature of CRC, with the liver, lungs, and peritoneum being common sites.
  • CRC cells release factors that facilitate organotropism before establishing premetastatic niches.

Purpose of the Study:

  • To comprehensively review the molecular mechanisms underlying organotropic metastasis in colorectal cancer.
  • To explore the potential of targeting organotropism for novel CRC therapeutic strategies.

Main Methods:

  • Review of literature focusing on metabolic reprogramming, tumor-derived exosomes, immune system interactions, and cancer cell-organ crosstalk in CRC metastasis.
  • Analysis of molecular pathways involved in the establishment of premetastatic niches and organ-specific colonization.

Main Results:

  • Metabolic reprogramming influences the ability of CRC cells to colonize distant organs.
  • Tumor-derived exosomes play a critical role in preparing metastatic sites.
  • Immune cell interactions and cancer cell-organ crosstalk are integral to CRC organotropic metastasis.

Conclusions:

  • Understanding the molecular drivers of CRC organotropic metastasis is essential for improving diagnosis and treatment.
  • Targeting organotropism presents a promising therapeutic avenue for colorectal cancer patients.
  • Further research into these mechanisms could lead to more effective, biomarker-based therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K